1 Table S1. Outlier Loci Detected by Deepgenomescan Using

Total Page:16

File Type:pdf, Size:1020Kb

1 Table S1. Outlier Loci Detected by Deepgenomescan Using Table S1. Outlier loci detected by DeepGenomeScan using geographic coordinates. Loci highlighted in red are detected by DeepGenomeScan but are not listed in Yang et al. (2012; Supplementary Table 4). RsID is annotated according to the dbSNP database released on 21st April, 2020. CHR BP (Grch37) BP (Grch38) rsID p.value Genes 1 1:4208918 1:4148858 rs9426495 3.8582E-104 1 1:175738168 1:175769032 rs6425357 2.0088E-105 2 2:20310668 2:20110907 rs11679737 1.2002E-111 LAPTM4A-DT 2 2:40289267 2:40062127 rs759361 5.5658E-104 SLC8A1-AS1 2 2:82495127 2:82268003 rs6726401 3.9451E-103 2 2:96660300 2:95994552 rs2579520 1.8176E-127 2 2:96672001 2:96006253 rs1917890 3.7698E-104 2 2:134333012 2:133575441 rs17816830 9.702E-105 NCKAP5 2 2:134350570 2:133592999 rs6715224 5.8745E-111 NCKAP5 2 2:134912243 2:134154672 rs2139309 1.7418E-191 MGAT5 2 2:134917005 2:134159434 rs11692586 9.2121E-151 MGAT5 2 2:134972732 2:134215161 rs11679218 0 MGAT5 2 2:134979966 2:134222395 rs1965183 5.3171E-107 MGAT5 2 2:135260071 2:134502500 rs503562 2.057E-153 TMEM163 2 2:135280039 2:134522468 rs579670 3.1477E-118 TMEM163 2 2:135285279 2:134527708 rs512375 0 TMEM163 2 2:135290221 2:134532650 rs655472 0 TMEM163 2 2:135290453 2:134532882 rs666614 0 TMEM163 2 2:135340840 2:134583270 rs842361 5.6717E-237 TMEM163 2 2:135393110 2:134635540 rs11684785 2.2164E-276 TMEM163 2 2:135430709 2:134673139 rs6745983 0 TMEM163 2 2:135469769 2:134712199 rs6747870 9.6117E-114 TMEM163 2 2:135483381 2:134725811 rs3739034 5.0357E-154 2 2:135483534 2:134725964 rs3739036 3.7269E-156 2 2:135539967 2:134782397 rs6430538 0 2 2:135602601 2:134845031 rs6430545 0 ACMSD 2 2:135606879 2:134849309 rs1530557 0 ACMSD 2 2:135612422 2:134854852 rs6430547 0 ACMSD 2 2:135618982 2:134861412 rs6706537 0 ACMSD 2 2:135623517 2:134865947 rs7593370 0 ACMSD 2 2:135629927 2:134872357 rs12469941 0 ACMSD, CCNT2-AS1 2 2:135637338 2:134879768 rs2166480 0 ACMSD, CCNT2-AS1 2 2:135657471 2:134899901 rs10176573 0 ACMSD, CCNT2-AS1 2 2:135693537 2:134935967 rs6743206 2.0048E-214 CCNT2 2 2:135694379 2:134936809 rs1374289 0 CCNT2 2 2:135694848 2:134937278 rs4953938 0 CCNT2 2 2:135737908 2:134980338 rs4954209 4.6215E-270 MAP3K19 2 2:135762344 2:135004774 rs16831243 2.8757E-253 MAP3K19 1 2 2:135762656 2:135005086 rs10197646 3.3948E-218 MAP3K19 2 2:135775130 2:135017560 rs7581382 0 MAP3K19 2 2:135803425 2:135045855 rs4954218 0 MAP3K19 2 2:135907088 2:135149518 rs6730157 0 RAB3GAP1 2 2:136388473 2:135630903 rs10187054 0 R3HDM1 2 2:136419961 2:135662391 rs1446584 0 R3HDM1 2 2:136420690 2:135663120 rs4954280 0 R3HDM1 2 2:136462661 2:135705091 rs2117511 3.0786E-143 R3HDM1 2 2:136499166 2:135741596 rs1438307 0 UBXN4, LOC107985946 2 2:136506927 2:135749357 rs6430585 0 UBXN4 2 2:136545844 2:135788274 rs1042712 0 LCT 2 2:136555525 2:135797955 rs2015532 0 LCT 2 2:136556182 2:135798612 rs3769013 2.3001E-307 LCT 2 2:136556480 2:135798910 rs3769012 0 LCT 2 2:136556805 2:135799235 rs872151 6.4599E-149 LCT 2 2:136557319 2:135799749 rs2322660 0 LCT 2 2:136561557 2:135803987 rs2304371 0 LCT 2 2:136571982 2:135814412 rs4954445 3.6282E-117 LCT 2 2:136614255 2:135856685 rs309180 0 MCM6 2 2:136628121 2:135870551 rs4988163 4.0179E-286 MCM6 2 2:136637350 2:135879780 rs16832138 1.5766E-116 2 2:136641593 2:135884023 rs7581814 0 2 2:136694905 2:135937335 rs7573555 0 DARS1 2 2:136702601 2:135945031 rs6743537 0 DARS1 2 2:136719173 2:135961603 rs6430594 0 DARS1 2 2:136765951 2:136008381 rs309137 0 2 2:136770509 2:136012939 rs12471781 0 2 2:136786651 2:136029081 rs12475139 0 2 2:136806774 2:136049204 rs7371606 0 2 2:136808949 2:136051379 rs11693502 0 2 2:136910273 2:136152703 rs6715785 0 2 2:136921703 2:136164133 rs10180515 2.2455E-281 2 2:136956733 2:136199163 rs7578292 3.7209E-216 2 2:136963794 2:136206224 rs12691876 1.3461E-265 2 2:136973781 2:136216211 rs1519528 9.1417E-244 LOC107985947 2 2:137037386 2:136279816 rs4954599 1.0298E-196 2 2:137057148 2:136299578 rs13008975 1.6878E-135 2 2:137058248 2:136300678 rs4296479 4.9792E-133 2 2:137058433 2:136300863 rs4599171 4.0031E-214 2 2:137197151 2:136439581 rs7561441 5.3311E-173 2 2:137300091 2:136542521 rs10205768 5.1224E-276 2 2:137341944 2:136584374 rs12691894 1.1911E-163 2 2 2:137433213 2:136675643 rs11681380 1.5164E-192 2 2:137475070 2:136717500 rs7582192 5.155E-212 2 2:137496806 2:136739236 rs10199153 8.9959E-130 2 2:137512698 2:136755128 rs7564005 2.1506E-128 2 2:137514418 2:136756848 rs1427591 1.253E-146 2 2:137610518 2:136852948 rs778207 2.4208E-196 THSD7B 2 2:137612229 2:136854659 rs778202 2.0497E-109 THSD7B 2 2:137614786 2:136857216 rs1429978 3.9634E-206 THSD7B 2 2:160867553 2:160011042 rs2667012 1.0935E-118 PLA2R1 2 2:160891688 2:160035177 rs17830904 6.4076E-116 PLA2R1 2 2:160906931 2:160050420 rs10929965 7.3545E-120 PLA2R1 2 2:160912652 2:160056141 rs925410 2.3118E-126 PLA2R1, LOC105373717 2 2:160914156 2:160057645 rs17831251 3.7725E-121 PLA2R1, LOC105373717 2 2:160914540 2:160058029 rs6707458 5.846E-116 PLA2R1, LOC105373717 2 2:160915106 2:160058595 rs16844715 4.6953E-126 PLA2R1, LOC105373717 2 2:166924472 2:166067962 rs1461197 2.2877E-104 SCN1A 2 2:174486590 2:173621862 rs6722856 2.9251E-127 LOC107985961 2 2:177977545 2:177112817 rs2588865 3.7631E-139 LOC105373760 2 2:177991618 2:177126890 rs2706137 3.1043E-172 LOC105373760 3 3:45846769 3:45805277 rs17763742 1.8336E-162 LOC107986082 3 3:81427818 3:81378667 rs275360 3.1048E-120 3 3:127416142 3:127697299 rs782440 1.8735E-121 MGLL 3 3:127417202 3:127698359 rs782437 9.6119E-114 MGLL 3 3:127426929 3:127708086 rs1071912 2.7892E-104 MGLL 3 3:178429939 3:178712151 rs9290663 4.5367E-112 KCNMB2, KCNMB2-AS1 3 3:178995657 3:179277869 rs9813206 3.7674E-125 4 4:14093170 4:14091546 rs7673306 4.0281E-109 4 4:38768533 4:38766912 rs10470854 4.5861E-114 4 4:38776303 4:38774682 rs11466652 5.0508E-141 TLR10 4 4:38776491 4:38774870 rs11096957 8.3115E-109 TLR10 4 4:38783964 4:38782343 rs4321646 1.4399E-155 TLR10 4 4:38787216 4:38785595 rs12233670 4.7111E-144 4 4:38894380 4:38892759 rs6835514 4.1487E-200 FAM114A1 4 4:38908038 4:38906417 rs4832790 7.1817E-108 FAM114A1 4 4:84909466 4:83988313 rs4693665 5.537E-127 LOC101928978 4 4:100260274 4:99339117 rs1693476 2.4983E-155 ADH1C 4 4:100262041 4:99340884 rs1789903 2.3041E-165 ADH1C 4 4:100263778 4:99342621 rs1789911 5.5025E-158 ADH1C 4 4:100285148 4:99363991 rs1154435 9.4022E-145 4 4:103243101 4:102321944 rs17278473 2.2816E-103 SLC39A8 4 4:112051824 4:111130668 rs294942 1.1955E-129 5 5:36368967 5:36368865 rs4602650 3.9055E-113 3 5 5:110472967 5:111137269 rs464275 2.278E-141 6 6:27987776 6:28019998 rs149976 5.1992E-136 6 6:28100640 6:28132862 rs1225710 5.0364E-157 ZSCAN16-AS1 6 6:28113373 6:28145595 rs1225715 1.3359E-139 ZKSCAN8 6 6:28391465 6:28423688 rs2859365 3.2334E-133 LOC105374997 6 6:28415572 6:28447795 rs13215804 1.458E-224 6 6:28417222 6:28449445 rs6903535 1.1153E-191 6 6:28542520 6:28574743 rs370520 7.3625E-166 ZBED9 6 6:28665362 6:28697585 rs7382146 5.3108E-300 LOC101929006, 6 6:29256420 6:29288643 rs1884123 2.2056E-105 LOC105375005 6 6:30103360 6:30135583 rs1541269 1.1572E-107 TRIM40 6 6:30152467 6:30184690 rs11158 4.2464E-119 TRIM26 6 6:30328192 6:30360415 rs3130351 1.0679E-104 6 6:30363351 6:30395574 rs3094034 2.9109E-102 6 6:30739972 6:30772195 rs3132605 2.572E-102 HCG20 6 6:31025713 6:31057936 rs2517524 7.1036E-144 HCG22 6 6:31030122 6:31062345 rs2517510 2.4694E-197 6 6:31030283 6:31062506 rs2523841 2.188E-123 6 6:31030425 6:31062648 rs2523840 4.7541E-127 6 6:31042070 6:31074293 rs2523883 4.2821E-181 6 6:31042306 6:31074529 rs2517489 2.4633E-192 6 6:31042608 6:31074831 rs2523881 6.9967E-188 6 6:31042769 6:31074992 rs2523880 2.4424E-165 6 6:31051388 6:31083611 rs2535318 1.4176E-189 6 6:31052098 6:31084321 rs2517471 9.6266E-197 6 6:31053867 6:31086090 rs2535306 5.342E-202 6 6:31172655 6:31204878 rs2894180 8.1758E-109 6 6:31255500 6:31287723 rs2524051 2.4487E-163 6 6:31265554 6:31297777 rs2524115 3.9166E-141 LINC02571, LOC112267902 6 6:31277686 6:31309909 rs1634788 6.1552E-102 LOC112267902 6 6:31333939 6:31366162 rs7761068 1.6372E-158 6 6:31336649 6:31368872 rs2523533 5.5187E-127 6 6:31379931 6:31412154 rs1063635 2.1436E-251 MICA 6 6:31777946 6:31810169 rs2075800 4.1936E-126 HSPA1L 6 6:31856070 6:31888293 rs486416 0 EHMT2 6 6:31883957 6:31916180 rs644045 7.5006E-221 C2 6 6:31919578 6:31951801 rs2072633 0 CFB, NELFE 6 6:32179896 6:32212119 rs2071286 2.5495E-111 NOTCH4 6 6:32200147 6:32232370 rs3134926 2.8449E-106 6 6:32216850 6:32249073 rs3115576 4.511E-241 6 6:32217367 6:32249590 rs3130311 2.0337E-237 6 6:32288190 6:32320413 rs574710 1.366E-230 TSBP1, TSBP1-AS1 4 6 6:32305690 6:32337913 rs926591 1.3828E-249 TSBP1, TSBP1-AS2 6 6:32313097 6:32345320 rs4959093 1.0302E-241 TSBP1, TSBP1-AS3 6 6:32389512 6:32421735 rs9268560 5.1383E-297 6 6:32408527 6:32440750 rs9268645 1.172E-227 HLA-DRA 6 6:32429758 6:32461981 rs9268858 2.0363E-156 6 6:32431147 6:32463370 rs9268877 0 6 6:32626272 6:32658495 rs9273363 5.5519E-129 HLA-DQB1-AS1 6 6:32635296 6:32667519 rs6908943 3.3296E-144 HLA-DQB1 6 6:32689529 6:32721752 rs9461799 2.3913E-199 6 6:32690001 6:32722224 rs9469240 2.4622E-170 6 6:32711782 6:32744005 rs2227127 9.9757E-175 HLA-DQA2 6 6:32712384 6:32744607 rs9276432 1.1768E-129 HLA-DQA2 6 6:32736144 6:32768367 rs9296044 6.0615E-120 6 6:32965942 6:32998165 rs176248 3.5831E-139 6 6:79190083 6:78480366 rs10943541 5.1113E-117 6 6:79212957 6:78503240 rs4632856 4.0872E-115 6 6:79232161 6:78522444 rs4706060 5.8085E-109 6 6:152942821 6:152621686 rs1744380 4.3781E-102 SYNE1 6 6:152950053 6:152628918 rs2057399 2.4192E-115 SYNE1 6 6:152966084 6:152644949 rs2758813 1.212E-121 6 6:153007917 6:152686782 rs2800629 8.0585E-128 LOC105378061
Recommended publications
  • Modulated in Intestinal Inflammation A
    BTNL2, a Butyrophilin/B7-Like Molecule, Is a Negative Costimulatory Molecule Modulated in Intestinal Inflammation This information is current as Heather A. Arnett, Sabine S. Escobar, Eva Gonzalez-Suarez, of September 28, 2021. Alison L. Budelsky, Lori A. Steffen, Norman Boiani, Ming Zhang, Gerald Siu, Avery W. Brewer and Joanne L. Viney J Immunol 2007; 178:1523-1533; ; doi: 10.4049/jimmunol.178.3.1523 http://www.jimmunol.org/content/178/3/1523 Downloaded from References This article cites 40 articles, 12 of which you can access for free at: http://www.jimmunol.org/content/178/3/1523.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 28, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology BTNL2, a Butyrophilin/B7-Like Molecule, Is a Negative Costimulatory Molecule Modulated in Intestinal Inflammation Heather A. Arnett,1* Sabine S.
    [Show full text]
  • Next Generation Exome Sequencing of Paediatric Inflammatory Bowel Disease Patients Identifies Rare and Novel Variants in Candida
    Gut Online First, published on April 28, 2012 as 10.1136/gutjnl-2011-301833 Inflammatory bowel disease ORIGINAL ARTICLE Gut: first published as 10.1136/gutjnl-2011-301833 on 28 April 2012. Downloaded from Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes Katja Christodoulou,1 Anthony E Wiskin,2 Jane Gibson,1 William Tapper,1 Claire Willis,2 Nadeem A Afzal,3 Rosanna Upstill-Goddard,1 John W Holloway,4 Michael A Simpson,5 R Mark Beattie,3 Andrew Collins,1 Sarah Ennis1 < Additional materials are ABSTRACT published online only. To view Background Multiple genes have been implicated by Significance of this study these files please visit the association studies in altering inflammatory bowel journal online (http://gut.bmj. com/content/early/recent). disease (IBD) predisposition. Paediatric patients often What is already known on this subject? manifest more extensive disease and a particularly < For numbered affiliations see Genome-wide association studies have impli- end of article. severe disease course. It is likely that genetic cated numerous candidate genes for inflamma- predisposition plays a more substantial role in this group. tory bowel disease (IBD), but evidence of Correspondence to Objective To identify the spectrum of rare and novel causality for specific variants is largely absent. Dr Sarah Ennis, Genetic variation in known IBD susceptibility genes using exome Furthermore, by design, genome-wide associa- Epidemiology and Genomic sequencing analysis in eight individual cases of childhood Informatics Group, Human tion studies are limited to the study of Genetics, Faculty of Medicine, onset severe disease.
    [Show full text]
  • Familial Vs. Sporadic Sarcoidosis: BTNL2 Polymorphisms, Clinical
    Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort Yves Pacheco, Alain Calender, Dominique Israël-Biet, Pascal Roy, Serge Lebecque, Vincent Cottin, Diane Bouvry, Hilario Nunes, Pascal Sève, Laurent Pérard, et al. To cite this version: Yves Pacheco, Alain Calender, Dominique Israël-Biet, Pascal Roy, Serge Lebecque, et al.. Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort. Orphanet Journal of Rare Diseases, BioMed Central, 2016, 11 (1), 10.1186/s13023-016-0546-4. hal- 01595465 HAL Id: hal-01595465 https://hal.archives-ouvertes.fr/hal-01595465 Submitted on 26 Sep 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution - ShareAlike| 4.0 International License Pacheco et al. Orphanet Journal of Rare Diseases (2016) 11:165 DOI 10.1186/s13023-016-0546-4 RESEARCH Open Access Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort Yves Pacheco1,11*, Alain Calender2, Dominique Israël-Biet3, Pascal Roy4, Serge Lebecque5, Vincent Cottin6, Diane Bouvry7, Hilario Nunes7, Pascal Sève8, Laurent Pérard9, Gilles Devouassoux8, Nathalie Freymond1, Chahira Khouatra6, Benoît Wallaert10, Raphaelle Lamy2, Mad-Hélénie Elsensohn4, Claire Bardel4, Dominique Valeyre7 and GSF group Abstract Background: The occurrence of familial forms of sarcoidosis (OMIM 181100) suggests a genetic predisposition.
    [Show full text]
  • 2027.Full.Pdf
    Butyrophilin-like 2 Modulates B7 Costimulation To Induce Foxp3 Expression and Regulatory T Cell Development in Mature T Cells This information is current as of September 28, 2021. Ryan M. Swanson, Marc A. Gavin, Sabine S. Escobar, James B. Rottman, Brian P. Lipsky, Shishir Dube, Li Li, Jeannette Bigler, Martin Wolfson, Heather A. Arnett and Joanne L. Viney J Immunol 2013; 190:2027-2035; Prepublished online 28 Downloaded from January 2013; doi: 10.4049/jimmunol.1201760 http://www.jimmunol.org/content/190/5/2027 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2013/01/28/jimmunol.120176 Material 0.DC1 References This article cites 40 articles, 18 of which you can access for free at: http://www.jimmunol.org/content/190/5/2027.full#ref-list-1 by guest on September 28, 2021 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606.
    [Show full text]
  • Functions to Inhibit T Cell Activation BTNL2, a Butyrophilin-Like
    BTNL2, a Butyrophilin-Like Molecule That Functions to Inhibit T Cell Activation Thang Nguyen, Xikui K. Liu, Yongliang Zhang and Chen Dong This information is current as of October 2, 2021. J Immunol 2006; 176:7354-7360; ; doi: 10.4049/jimmunol.176.12.7354 http://www.jimmunol.org/content/176/12/7354 Downloaded from References This article cites 40 articles, 10 of which you can access for free at: http://www.jimmunol.org/content/176/12/7354.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on October 2, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology BTNL2, a Butyrophilin-Like Molecule That Functions to Inhibit T Cell Activation1 Thang Nguyen,2* Xikui K. Liu,2† Yongliang Zhang,† and Chen Dong3† B7 family members regulate T cell activation and tolerance. Although butyrophilin proteins share sequence homology with the B7 molecules, it is unclear whether they have any function in immune responses.
    [Show full text]
  • (AMD) and Their Role in the Regulation of Gene Expression
    Genetic Variants with Significant Association to Age-Related Macular Degeneration (AMD) and their Role in the Regulation of Gene Expression Dissertation zur Erlangung des Doktorgrades der Biomedizinischen Wissenschaften (Dr. rer. physiol.) der Fakultät für Medizin der Universität Regensburg vorgelegt von Tobias Strunz aus Marktredwitz im Jahr 2020 Genetic Variants with Significant Association to Age-Related Macular Degeneration (AMD) and their Role in the Regulation of Gene Expression Dissertation zur Erlangung des Doktorgrades der Biomedizinischen Wissenschaften (Dr. rer. physiol.) der Fakultät für Medizin der Universität Regensburg vorgelegt von Tobias Strunz aus Marktredwitz im Jahr 2020 Dekan: Prof. Dr. Dirk Hellwig Betreuer: Prof. Dr. Bernhard H.F. Weber Tag der mündlichen Prüfung: 02.12.2020 Parts of this work have already been published in peer-reviewed journals in an open access format: Strunz T, Grassmann F, Gayán J, Nahkuri S, Souza-Costa D, Maugeais C, Fauser S, Nogoceke E, Weber BHF (2018) A mega-analysis of expression quantitative trait loci (eQTL) provides insight into the regulatory architecture of gene expression variation in liver. Sci Rep 8: 5865. Strunz T, Lauwen S, Kiel C, den Hollander A, Weber BHF (2020) A transcriptome- wide association study based on 27 tissues identifies 106 genes potentially relevant for disease pathology in age-related macular degeneration. Sci Rep 10: 1584. Strunz T, Kiel C, Grassmann F, Ratnapriya R, Kwicklis M, Karlstetter M, Fauser S, Swaroop A, Arend N, Langmann T, Wolf A, Weber BHF (2020) A mega-analysis of expression quantitative trait loci in retinal tissue. PLoS Genet 16: e1008934. Kiel C, Berber P, Karlstetter M, Aslanidis A, Strunz T, Langmann T, Grassmann F, Weber BHF (2020) A Circulating MicroRNA Profile in a Laser-Induced Mouse Model of Choroidal Neovascularization.
    [Show full text]
  • Genetic Landscape of Nonobstructive Azoospermia and New Perspectives for the Clinic
    Journal of Clinical Medicine Review Genetic Landscape of Nonobstructive Azoospermia and New Perspectives for the Clinic Miriam Cerván-Martín 1,2, José A. Castilla 2,3,4, Rogelio J. Palomino-Morales 2,5 and F. David Carmona 1,2,* 1 Departamento de Genética e Instituto de Biotecnología, Universidad de Granada, Centro de Investigación Biomédica (CIBM), Parque Tecnológico Ciencias de la Salud, Av. del Conocimiento, s/n, 18016 Granada, Spain; [email protected] 2 Instituto de Investigación Biosanitaria ibs.GRANADA, Av. de Madrid, 15, Pabellón de Consultas Externas 2, 2ª Planta, 18012 Granada, Spain; [email protected] (J.A.C.); [email protected] (R.J.P.-M.) 3 Unidad de Reproducción, UGC Obstetricia y Ginecología, HU Virgen de las Nieves, Av. de las Fuerzas Armadas 2, 18014 Granada, Spain 4 CEIFER Biobanco—NextClinics, Calle Maestro Bretón 1, 18004 Granada, Spain 5 Departamento de Bioquímica y Biología Molecular I, Universidad de Granada, Facultad de Ciencias, Av. de Fuente Nueva s/n, 18071 Granada, Spain * Correspondence: [email protected]; Tel.: +34-958-241-000 (ext 20170) Received: 29 December 2019; Accepted: 16 January 2020; Published: 21 January 2020 Abstract: Nonobstructive azoospermia (NOA) represents the most severe expression of male infertility, involving around 1% of the male population and 10% of infertile men. This condition is characterised by the inability of the testis to produce sperm cells, and it is considered to have an important genetic component. During the last two decades, different genetic anomalies, including microdeletions of the Y chromosome, karyotype defects, and missense mutations in genes involved in the reproductive function, have been described as the primary cause of NOA in many infertile men.
    [Show full text]
  • Genetics and Epigenetics in Asthma
    International Journal of Molecular Sciences Review Genetics and Epigenetics in Asthma Polyxeni Ntontsi 1, Andreas Photiades 1 , Eleftherios Zervas 1 , Georgina Xanthou 2 and Konstantinos Samitas 1,2,* 1 7th Respiratory Medicine Department and Asthma Center, Athens Chest Hospital “Sotiria”, 11527 Athens, Greece; [email protected] (P.N.); [email protected] (A.P.); [email protected] (E.Z.) 2 Cellular Immunology Laboratory, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece; [email protected] * Correspondence: [email protected]; Tel.: +30-210-778-1720 Abstract: Asthma is one of the most common respiratory disease that affects both children and adults worldwide, with diverse phenotypes and underlying pathogenetic mechanisms poorly understood. As technology in genome sequencing progressed, scientific efforts were made to explain and pre- dict asthma’s complexity and heterogeneity, and genome-wide association studies (GWAS) quickly became the preferred study method. Several gene markers and loci associated with asthma suscep- tibility, atopic and childhood-onset asthma were identified during the last few decades. Markers near the ORMDL3/GSDMB genes were associated with childhood-onset asthma, interleukin (IL)33 and IL1RL1 SNPs were associated with atopic asthma, and the Thymic Stromal Lymphopoietin (TSLP) gene was identified as protective against the risk to TH2-asthma. The latest efforts and advances in identifying and decoding asthma susceptibility are focused on epigenetics, heritable characteristics that affect gene expression without altering DNA sequence, with DNA methylation being the most described mechanism. Other less studied epigenetic mechanisms include histone modifications and alterations of miR expression. Recent findings suggest that the DNA methylation pattern is tissue Citation: Ntontsi, P.; Photiades, A.; and cell-specific.
    [Show full text]
  • The COVID-19 Gene and Drug Set Library
    The COVID-19 Gene and Drug Set Library Maxim V. Kuleshov1, Daniel J.B. Clarke1, Eryk Kropiwnicki1, Kathleen M. Jagodnik1, Alon Bartal1, John E. Evangelista1, Abigail Zhou1, Laura B. Ferguson2, Alexander Lachmann1, Avi Ma’ayan1,* 1Department of Pharmacological Sciences; Mount Sinai Center for Bioinformatics; Big Data to Knowledge, Library of Integrated Network-based Cellular Signatures, Data Coordination and Integration Center (BD2K-LINCS DCIC); Knowledge Management Center for Illuminating the Druggable Genome (KMC-IDG); Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1603, New York, NY 10029, USA 2Department of Neurology; Dell Medical School; University of Texas at Austin; 1601 Trinity Street, Bldg B, Austin, TX 78712, USA. To whom correspondence should be addressed: [email protected] Abstract The coronavirus (CoV) severe acute respiratory syndrome (SARS)-CoV-2 (COVID-19) pandemic has received rapid response by the research community to offer suggestions for repurposing of approved drugs as well as to improve our understanding of the COVID-19 viral life cycle molecular mechanisms. In a short period, tens of thousands of research preprints and other publications have emerged including those that report lists of experimentally validated drugs and compounds as potential COVID-19 therapies. In addition, gene sets from interacting COVID-19 virus-host proteins and differentially expressed genes when comparing infected to uninfected cells are being published at a fast rate. To organize this rapidly accumulating knowledge, we developed the COVID-19 Gene and Drug Set Library (https://amp.pharm.mssm.edu/covid19/), a collection of gene and drug sets related to COVID-19 research from multiple sources.
    [Show full text]
  • FARE2017 WINNERS Sorted by Institute/Center
    FARE2017 WINNERS Sorted By Institute/Center NIH Clinical Center (CC) Zachary Lerner Postdoctoral FellowPostdoctoral Fellow Clinical and Translational Research A Robotic Exoskeleton to Treat Crouch Gait from Cerebral Palsy: Design and Initial Clinical Evaluation Cerebral palsy (CP) is the most prevalent childhood physical disability and adversely affects walking and other motor abilities. Crouch gait, a pathological walking pattern characterized by excessive knee flexion, is one of the most common gait disorders observed in children with CP. Effective treatment of crouch during childhood is critical to maintain mobility into adulthood, yet current interventions do not adequately eliminate or alleviate crouch in most patients. Wearable robotic exoskeletons have the potential to improve crouch gait by providing on demand assistance during walking. However, no exoskeletons suitable to treat children are commercially available, and no evidence exists regarding the feasibility or efficacy of utilizing motorized assistance to alleviate knee flexion from crouch gait. Enhanced knowledge of neuromuscular adaptations to powered assistance in children with crouch gait is needed to optimize this treatment approach. To meet these needs, we developed the first lower- extremity exoskeleton intended to treat crouch gait by providing powered knee extension assistance at different phases of the gait cycle. We evaluated the effects of powered knee extension assistance on knee motion, and knee flexor and extensor muscle activity in four children with crouch gait from CP. The exoskeleton was effective in reducing crouch in three of the four participants compared to their baseline gait pattern. The reduction in crouch was clinically significant (greater than 10 degrees) in two of the participants.
    [Show full text]
  • Functional Characterization of Potential New Agents for Cancer Immunotherapy
    Functional Characterization of Potential New Agents for Cancer Immunotherapy The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:39010116 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Functional Characterization of Potential New Agents for Cancer Immunotherapy Xiaoxu Wang A Thesis Submitted to the Faculty of The Harvard Medical School in Partial Fulfillment of the Requirements for the Degree of Master of Medical Sciences in Immunology Harvard University Boston, Massachusetts. May, 2018 Thesis Advisor: Dr. Gordon Freeman Xiaoxu Wang Functional Characterization of Potential New Agents for Cancer Immunotherapy Abstract PD-1/PD-L1 checkpoint blockade has demonstrated promise in a variety of malignancies. The blockade of T cell inhibitory molecules PD-1 and PD-L1 can rejuvenate T cells and improve tumor cell killing. However, the overall response rate of PD-1/PD-L1 immunotherapy is only about 20-30%. One promising method to improve cancer immunotherapy is combinatory immunotherapies that target new receptors/ligands regulating T cell activity, so the functional characterization of these new receptors/ligands is urgent. Due to the functional importance of the B7 superfamily in T cell activation, I studied T cell regulating functions of two poorly characterized B7 superfamily members, IgC domain-truncated CD86 and butyrophilin-like 2 (BTNL2).
    [Show full text]
  • Genetic Impacts on DNA Methylation: Research Findings and Future Perspectives
    Villicaña and Bell Genome Biology (2021) 22:127 https://doi.org/10.1186/s13059-021-02347-6 REVIEW Open Access Genetic impacts on DNA methylation: research findings and future perspectives Sergio Villicaña* and Jordana T. Bell *Correspondence: [email protected] Abstract Department of Twin Research and Multiple recent studies highlight that genetic variants can have strong impacts on a Genetic Epidemiology, St. Thomas’ Hospital, King’s College London, 3rd significant proportion of the human DNA methylome. Methylation quantitative trait Floor, South Wing, Block D, London loci, or meQTLs, allow for the exploration of biological mechanisms that underlie SE1 7EH, UK complex human phenotypes, with potential insights for human disease onset and progression. In this review, we summarize recent milestones in characterizing the human genetic basis of DNA methylation variation over the last decade, including heritability findings and genome-wide identification of meQTLs. We also discuss challenges in this field and future areas of research geared to generate insights into molecular processes underlying human complex traits. Keywords: DNA methylation, Heritability, GWAS, Methylation quantitative trait loci, meQTL Introduction The complexity of the human genome lies not only in its composition of billions of base pairs, but also in the chemical modifications that make it interpretable to enzymes and other molecular factors, through epigenetic mechanisms. DNA methylation has been the most widely studied epigenetic mark since 1948 when it was first reported [1]. In humans, DNA methylation consists of the covalent addition of a methyl group to cytosine residues—predominantly at CpG sites—by a family of enzymes called DNA methyltrans- ferases (DNMTs) [2, 3].
    [Show full text]